|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Gaeckler, Anja; Schoenermarck, Ulf; Dobronravov, Vladimir; La Manna, Gaetano; Denker, Andrew; Liu, Peng; Vinogradova, Maria; Yoon, Sung-Soo und Praga, Manuel
(2021):
Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis.
In: Springer Nature Nephrology, Bd. 22, Nr. 1, 5
2020
Fanouriakis, Antonis; Kostopoulou, Myrto; Cheema, Kim; Anders, Hans-Joachim; Aringer, Martin; Bajema, Ingeborg; Boletis, John; Frangou, Eleni; Houssiau, Frederic A.; Hollis, Jane; Karras, Adexandre; Marchiori, Francesca; Marks, Stephen D.; Moroni, Gabriella; Mosca, Marta; Parodis, Ioannis; Praga, Manuel; Schneider, Matthias; Smolen, Josef S.; Tesar, Vladimir; Trachana, Maria; van Vollenhoven, Ronald F.; Voskuyl, Alexandre E.; Teng, Y. K. Onno; van Leew, Bernadette; Bertsias, George; Jayne, David und Boumpas, Dimitrios T.
(2020):
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
In: Annals of the Rheumatic Diseases, Bd. 79, Nr. 6: S. 713-723
[PDF, 556kB]